Showing 341 - 360 results of 68,463 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ((( 50 c decrease ) OR ( 5 step decrease ))))', query time: 1.06s Refine Results
  1. 341
  2. 342

    Spatial stability is decreased in APP/PS1 mice in both dCA1 and vCA1. by Udaysankar Chockanathan (18510288)

    Published 2024
    “…<p>(A) In dCA1, stability score was significantly decreased in APP/PS1 mice relative to C57BL/6 mice (mean ± std: C57BL/6 = -0.009 ± 0.292, APP/PS1 = -0.1845 ± 0.256, p < 10<sup>−6</sup>, two-sided Wilcoxon rank-sum test, n<sub>C57BL/6</sub> = 295 units from 5 recording sessions, n<sub>APP/PS1</sub> = 167 units from 4 recording sessions). …”
  3. 343
  4. 344
  5. 345

    Figure 5 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

    Published 2025
    “…MFI, mean fluorescence intensity. <b>D,</b> A schematic representation of perforin maturation. …”
  6. 346
  7. 347
  8. 348
  9. 349
  10. 350
  11. 351
  12. 352
  13. 353

    Training steps of the improved YOLOv4-Tiny. by Fuxing He (19555871)

    Published 2024
    “…Meanwhile, the improved model achieves a processing efficiency of 85 frames/s. In addition, compared with the traditional trajectory prediction model, the constructed model performs the best in table tennis ball trajectory prediction, with errors of 4.5 mm, 25.3 mm, and 35.58 mm. …”
  14. 354

    The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

    Published 2020
    “…<p>(A) The GluN2B-C456Y mutation strongly decreases diheteromeric GluN1/GluN2B NMDAR currents in <i>Xenopus</i> oocytes. …”
  15. 355
  16. 356
  17. 357

    A summary of the included study characteristics. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  18. 358
  19. 359
  20. 360